| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5682799 | La Presse Médicale | 2017 | 5 Pages |
Abstract
The past 20 years has witnessed tremendous progress in our understanding of Parkinson's disease. It is now well established that α-synuclein, a presynaptic neuronal protein, is not only a marker but also an actor of the disease. In this review, we discuss the advances that have been obtained in neuropathology using α-synuclein immunohistochemistry and the role of this protein in the spread of the disease.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Alice Prigent, Arthur Lionnet, Anne-Gaëlle Corbillé, Pascal Derkinderen,